Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-096811
Filing Date
2024-11-12
Accepted
2024-11-12 16:16:35
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0218728-10q_therapeutics.htm   iXBRL 10-Q 556593
2 CERTIFICATION ea021872801ex31-1_therap.htm EX-31.1 9499
3 CERTIFICATION ea021872801ex31-2_therap.htm EX-31.2 9502
4 CERTIFICATION ea021872801ex32-1_therap.htm EX-32.1 4293
5 CERTIFICATION ea021872801ex32-2_therap.htm EX-32.2 4299
  Complete submission text file 0001213900-24-096811.txt   4291789

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE txmd-20240930.xsd EX-101.SCH 46785
7 XBRL CALCULATION FILE txmd-20240930_cal.xml EX-101.CAL 37928
8 XBRL DEFINITION FILE txmd-20240930_def.xml EX-101.DEF 212133
9 XBRL LABEL FILE txmd-20240930_lab.xml EX-101.LAB 401536
10 XBRL PRESENTATION FILE txmd-20240930_pre.xml EX-101.PRE 225945
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0218728-10q_therapeutics_htm.xml XML 439130
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 241448440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)